579 related articles for article (PubMed ID: 11290773)
1. NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death.
Zheng Y; Ouaaz F; Bruzzo P; Singh V; Gerondakis S; Beg AA
J Immunol; 2001 Apr; 166(8):4949-57. PubMed ID: 11290773
[TBL] [Abstract][Full Text] [Related]
2. NF-kappaB regulates Fas/APO-1/CD95- and TCR- mediated apoptosis of T lymphocytes.
Dudley E; Hornung F; Zheng L; Scherer D; Ballard D; Lenardo M
Eur J Immunol; 1999 Mar; 29(3):878-86. PubMed ID: 10092091
[TBL] [Abstract][Full Text] [Related]
3. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling.
Chen X; Kandasamy K; Srivastava RK
Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723
[TBL] [Abstract][Full Text] [Related]
4. NF-kappa B-dependent Fas ligand expression.
Hsu SC; Gavrilin MA; Lee HH; Wu CC; Han SH; Lai MZ
Eur J Immunol; 1999 Sep; 29(9):2948-56. PubMed ID: 10508269
[TBL] [Abstract][Full Text] [Related]
5. TNF receptor 2-deficient CD8 T cells are resistant to Fas/Fas ligand-induced cell death.
Teh HS; Seebaran A; Teh SJ
J Immunol; 2000 Nov; 165(9):4814-21. PubMed ID: 11046004
[TBL] [Abstract][Full Text] [Related]
6. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3.
Delgado M; Ganea D
J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682
[TBL] [Abstract][Full Text] [Related]
7. Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression.
Baetu TM; Kwon H; Sharma S; Grandvaux N; Hiscott J
J Immunol; 2001 Sep; 167(6):3164-73. PubMed ID: 11544302
[TBL] [Abstract][Full Text] [Related]
8. A novel NF-kappa B/Rel site in intron 1 cooperates with proximal promoter elements to mediate TNF-alpha-induced transcription of the human polymeric Ig receptor.
Schjerven H; Brandtzaeg P; Johansen FE
J Immunol; 2001 Dec; 167(11):6412-20. PubMed ID: 11714807
[TBL] [Abstract][Full Text] [Related]
9. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis.
Owyang AM; Tumang JR; Schram BR; Hsia CY; Behrens TW; Rothstein TL; Liou HC
J Immunol; 2001 Nov; 167(9):4948-56. PubMed ID: 11673501
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the expression of CD95 ligand, receptor activator of nuclear factor-kappa B ligand (RANKL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-alpha during T cell activation.
Wang R; Zhang L; Zhang X; Moreno J; Luo X; Tondravi M; Shi Y
J Immunol; 2001 Feb; 166(3):1983-90. PubMed ID: 11160247
[TBL] [Abstract][Full Text] [Related]
11. NF-kappa B1 p50 is required for BLyS attenuation of apoptosis but dispensable for processing of NF-kappa B2 p100 to p52 in quiescent mature B cells.
Hatada EN; Do RK; Orlofsky A; Liou HC; Prystowsky M; MacLennan IC; Caamano J; Chen-Kiang S
J Immunol; 2003 Jul; 171(2):761-8. PubMed ID: 12847243
[TBL] [Abstract][Full Text] [Related]
12. NF-kappa B subunit-specific regulation of the interleukin-8 promoter.
Kunsch C; Rosen CA
Mol Cell Biol; 1993 Oct; 13(10):6137-46. PubMed ID: 8413215
[TBL] [Abstract][Full Text] [Related]
13. Lack of essential role of NF-kappa B p50, RelA, and cRel subunits in virus-induced type 1 IFN expression.
Wang X; Hussain S; Wang EJ; Wang X; Li MO; García-Sastre A; Beg AA
J Immunol; 2007 Jun; 178(11):6770-6. PubMed ID: 17513724
[TBL] [Abstract][Full Text] [Related]
14. TRAIL/Apo-2 ligand induces primary plasma cell apoptosis.
Ursini-Siegel J; Zhang W; Altmeyer A; Hatada EN; Do RK; Yagita H; Chen-Kiang S
J Immunol; 2002 Nov; 169(10):5505-13. PubMed ID: 12421926
[TBL] [Abstract][Full Text] [Related]
15. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation.
Qin Y; Camoretti-Mercado B; Blokh L; Long CG; Ko FD; Hamann KJ
J Immunol; 2002 Oct; 169(7):3536-44. PubMed ID: 12244143
[TBL] [Abstract][Full Text] [Related]
16. Regulation of developing B cell survival by RelA-containing NF-kappa B complexes.
Prendes M; Zheng Y; Beg AA
J Immunol; 2003 Oct; 171(8):3963-9. PubMed ID: 14530314
[TBL] [Abstract][Full Text] [Related]
17. c-Rel is required for chromatin remodeling across the IL-2 gene promoter.
Rao S; Gerondakis S; Woltring D; Shannon MF
J Immunol; 2003 Apr; 170(7):3724-31. PubMed ID: 12646638
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.
Bunting K; Rao S; Hardy K; Woltring D; Denyer GS; Wang J; Gerondakis S; Shannon MF
J Immunol; 2007 Jun; 178(11):7097-109. PubMed ID: 17513759
[TBL] [Abstract][Full Text] [Related]
19. Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment.
Chan H; Bartos DP; Owen-Schaub LB
Mol Cell Biol; 1999 Mar; 19(3):2098-108. PubMed ID: 10022897
[TBL] [Abstract][Full Text] [Related]
20. T cell receptor ligation triggers novel nonapoptotic cell death pathways that are Fas-independent or Fas-dependent.
Davidson WF; Haudenschild C; Kwon J; Williams MS
J Immunol; 2002 Dec; 169(11):6218-30. PubMed ID: 12444127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
